Literature DB >> 8219842

Hypertension and the J-curve. How low should you go?

J Onrot1.   

Abstract

Recent analyses of treated blood pressure versus events suggest that drug treatment might result in an increase in coronary events or mortality at treated diastolic pressures below 80 mm Hg (the "J-curve"). However, this contention is highly controversial. Both sides of the argument are examined and a balanced approach for target blood pressure goals on treatment is outlined.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8219842      PMCID： PMC2379880     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  12 in total

1.  White coat phenomenon in patients receiving antihypertensive therapy.

Authors:  M G Myers; R A Reeves
Journal:  Am J Hypertens       Date:  1991-10       Impact factor: 2.689

Review 2.  Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia.

Authors:  J S Floras
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

3.  Bone disease after jejuno-ileal bypass for obesity.

Authors:  J E Compston; L W Horton; M F Laker; A B Ayers; J S Woodhead; H J Bull; J C Gazet; T R Pilkington
Journal:  Lancet       Date:  1978-07-01       Impact factor: 79.321

4.  The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the Primary Prevention Trial in Gothenburg, Sweden.

Authors:  O G Samuelsson; L W Wilhelmsen; K M Pennert; H Wedel; G L Berglund
Journal:  J Hypertens       Date:  1990-06       Impact factor: 4.844

5.  Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension.

Authors:  S Strandgaard
Journal:  Circulation       Date:  1976-04       Impact factor: 29.690

6.  Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy.

Authors:  J E Brush; R O Cannon; W H Schenke; R O Bonow; M B Leon; B J Maron; S E Epstein
Journal:  N Engl J Med       Date:  1988-11-17       Impact factor: 91.245

7.  Benefits and potential harm of lowering high blood pressure.

Authors:  J M Cruickshank; J M Thorp; F J Zacharias
Journal:  Lancet       Date:  1987-03-14       Impact factor: 79.321

8.  Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension.

Authors:  I M Stewart
Journal:  Lancet       Date:  1979-04-21       Impact factor: 79.321

9.  Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries.

Authors:  M L Marcus; D B Doty; L F Hiratzka; C B Wright; C L Eastham
Journal:  N Engl J Med       Date:  1982-11-25       Impact factor: 91.245

10.  Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors:  S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321
View more
  1 in total

1.  How lifespan associated genes modulate aging changes: lessons from analysis of longitudinal data.

Authors:  Anatoliy I Yashin; Konstantin G Arbeev; Deqing Wu; Liubov S Arbeeva; Alexander Kulminski; Igor Akushevich; Irina Culminskaya; Eric Stallard; Svetlana V Ukraintseva
Journal:  Front Genet       Date:  2013-01-22       Impact factor: 4.599
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.